Literature DB >> 2445753

Expression of human gamma-globin genes in human erythroleukemia (K562) cells.

M Donovan-Peluso1, S Acuto, M Swanson, C Dobkin, A Bank.   

Abstract

K562 cells express embryonic (epsilon) and fetal (gamma) globins and hemoglobins but not adult (beta) globin. To define the cis acting regulatory elements involved in the discrimination between gamma and beta genes, we have constructed chimeric genes composed of portions of gamma and beta and evaluated their expression in stable K562 transfectants. A gamma beta fusion gene containing gamma 5' sequences to the EcoRI site in exon 3 and beta sequences 3' is expressed at 10-40% that of the endogenous gamma level. In 50% of the lines, this fusion gene appropriately increases its expression in response to hemin, an inducer of endogenous globin gene expression in K562 cells. In contrast, a beta gamma fusion gene, containing beta sequences 5' to the EcoRI site in exon 3 and gamma sequences 3', is neither expressed nor correctly initiated. A beta gene containing gamma-intervening sequence (IVS) 2 accumulates an mRNA transcript when analyzed with a 3' beta probe. However, no correctly initiated beta mRNA is observed. A gamma gene with beta-IVS 2 is only inducible in one of six expressing clones. All the results are consistent with the presence of stage-specific trans acting factors in K562 cells that stimulate expression of gamma genes and suggest a significant role for gamma-IVS 2 in gamma gene expression.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2445753

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Contribution of β-globin cluster polymorphisms to raise fetal hemoglobin levels in normal adults.

Authors:  Latifa Jouini; Amina Bibi; Faida Ouali; Sondess Hadj Fredj; Fekria Ouennich; Hajer Siala; Taieb Messaoud; Slaheddine Fattoum
Journal:  Mol Biol Rep       Date:  2011-09-27       Impact factor: 2.316

2.  G gamma and A gamma globin genes are identical from -471 of the promoter midway through gamma IVSII in a Benin beta s haplotype associated with elevated fetal hemoglobin.

Authors:  N Mishima; E C Brinson; P F Milner; J G Gilman
Journal:  Am J Hum Genet       Date:  1991-06       Impact factor: 11.025

3.  DNA replication timing of the human beta-globin domain is controlled by histone modification at the origin.

Authors:  Alon Goren; Amalia Tabib; Merav Hecht; Howard Cedar
Journal:  Genes Dev       Date:  2008-04-28       Impact factor: 11.361

4.  A 46 base pair enhancer sequence within the locus activating region is required for induced expression of the gamma-globin gene during erythroid differentiation.

Authors:  B Sorrentino; P Ney; D Bodine; A W Nienhius
Journal:  Nucleic Acids Res       Date:  1990-05-11       Impact factor: 16.971

5.  High-density SNP genotyping to define beta-globin locus haplotypes.

Authors:  Li Liu; Shalini Muralidhar; Manisha Singh; Caprice Sylvan; Inderdeep S Kalra; Charles T Quinn; Onyinye C Onyekwere; Betty S Pace
Journal:  Blood Cells Mol Dis       Date:  2008-10-01       Impact factor: 3.039

6.  Erythroid expression and DNAaseI-hypersensitive sites of the carbonic anhydrase 1 gene.

Authors:  J Sowden; M Edwards; K Morrison; P H Butterworth; Y H Edwards
Journal:  Biochem J       Date:  1992-12-01       Impact factor: 3.857

7.  Identification of a stage selector element in the human gamma-globin gene promoter that fosters preferential interaction with the 5' HS2 enhancer when in competition with the beta-promoter.

Authors:  S M Jane; P A Ney; E F Vanin; D L Gumucio; A W Nienhuis
Journal:  EMBO J       Date:  1992-08       Impact factor: 11.598

8.  Detection of four rare thalassemia variants using Single-molecule realtime sequencing.

Authors:  Shiqiang Luo; Xingyuan Chen; Dingyuan Zeng; Ning Tang; Dejian Yuan; Bailing Liu; Lizhu Chen; Qingyan Zhong; Jiaqi Li; Yinyin Liu; Jianping Chen; Xiaoyuan Wang; Tizhen Yan
Journal:  Front Genet       Date:  2022-09-02       Impact factor: 4.772

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.